Sex, Gender, and the Regulation of Prescription Drugs: Omissions and Opportunities
, Andreea C. Brabete 1, Mira Maximos 1,3,4, Ella Huber 1, Alice Li 1, Mê-Linh Lê 5, Sherif Eltonsy 6 and Madeline Boscoe 7,8
Round 1
Reviewer 1 Report
Gender-related factors affect prescribing, access to drugs, and desire for specific prescribed therapies. This article draws on a policy-research partnership project that examined the lifecycle management of prescription drugs.
Abstract: Please clearly state your objectives in the abstract. the issue of clinical trials mentioned in your literature is not being reflected in the abstract.
Methods: Please clearly state your inclusion and exclusion criteria. How the articles were selected? How the search strategy was established?
English language: There is a need to improve the flow of the manuscript. English language editing is required.
Similarity index: The similarity index (turnitin report) is 49%. Please reduce it.
Author Response
Thank you for your comments!
Author Response File: 
Author Response.docx
Reviewer 2 Report
The manuscript is very interesting. I would recommend accepting it in present form.
Author Response
Thank you for your review!
Reviewer 3 Report
Very interesting article and topic. Please find my comments below.
1. Can you please provide some more information regarding sex and gender-based analysis plus and what this actually is?
2. In your materials and methods you say that you reviewed "four documents from two websites" - what are these websites and how did you find them?
Author Response
Thank you for your comments and suggestions!
Author Response File: Author Response.docx
